BioNano Genomics (BNGO) Revenue
BioNano Genomics Revenue
BioNano Genomics had a revenue of 8.17M in the quarter ending Jun 30, 2026, with 22.19%. This bring the company's revenue in the last twelve months to 30.18M, Increased 5.00%. In the fiscal year ending Dec 31, 2025, BioNano Genomics had annual revenue of 28.51M with -7.37% growth.
- Revenue (ttm)
- 30.18M
- Revenue Growth
- ―
- P/S Ratio
- 10.59
- Revenue/Employee
- MXN 296,958
- Employees
- 96
- Market Cap
- MXN 301.96M
Revenue Chart
BioNano Genomics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.51M | -2.27M | -7.37% |
| Mar 31, 2025 | 30.78M | -5.34M | -14.79% |
| Dec 31, 2023 | 36.12M | 8.31M | 29.90% |
| Dec 31, 2022 | 27.80M | 9.82M | 54.62% |
| Dec 31, 2021 | 17.98M | 9.48M | 111.47% |
| Dec 31, 2020 | 8.50M | -1.63M | -16.06% |
| Dec 31, 2019 | 10.13M | -1.87M | -15.59% |
| Dec 31, 2018 | 12.00M | 2.50M | 26.26% |
| Dec 31, 2017 | 9.51M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| MX:BNGO | 30.18M |